Abstract | INTRODUCTION: Some guidelines recommend an early voiding cystourethrography (VCUG) after endoscopic treatment of vesicoureteral reflux (VUR), but there's no consensus if it's necessary a long-term follow-up in these patients. The aim of our study is analyze if it's necessary a delayed VCUG after initial successful treatment with Dx/HA. MATERIAL AND METHOD: We have reviewed all medical charts of patients that underwent Dx/HA treatment from 2006 to 2010. We have selected patients with initial successful treatment and more than 3 years of radiological and clinical follow-up. We have analyzed late clinical and radiological outcomes. RESULTS: One hundred and sixty children with 228 refluxing ureters underwent Dx/HA endoscopic treatment with a mean follow-up of 52.13 months. Early VCUG was performed in 215 ureters with an initial successful rate of 84.1%. The group of study was 94/215 ureters with more than 3 years of follow-up with a delayed VCUG. VUR was still resolved in 79,8% of the ureters. Clinical success rate was 91.7%. The incidence of febrile urinary tract infection in those patients with cured VUR and those with a relapsed VUR was 8 and 15%, respectively; but there were no significant differences. We have not found any variable related with relapsed VUR except those ureters that initially received 2 injections (P<.05). CONCLUSION: If our objective in the treatment of VUR is to reduce the incidence of febrile urinary tract infection it is not necessary to perform a delayed VCUG even though the long-term radiological outcomes is worse than clinical outcome.
|
Authors | L García-Aparicio, E Blázquez-Gómez, A Vila Santandreu, J A Camacho Diaz, J Vila-Cots, M Ramos Cebrian, I de Haro, O Martin, X Tarrado |
Journal | Actas urologicas espanolas
(Actas Urol Esp)
Vol. 40
Issue 10
Pg. 635-639
(Dec 2016)
ISSN: 1699-7980 [Electronic] Spain |
Vernacular Title | ¿Es necesario realizar una cistouretrografía miccional seriada (CUMS) tardía tras el tratamiento endoscópico exitoso inicial con copolímero de dextranómreo/ácido hialurónico (Dx/HA) para el reflujo vesicoureteral (RVU)? |
PMID | 27161091
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 AEU. Publicado por Elsevier España, S.L.U. All rights reserved. |
Chemical References |
- Dextrans
- dextranomer-hyaluronic acid copolymer
- Hyaluronic Acid
|
Topics |
- Child, Preschool
- Cystography
- Cystoscopy
- Dextrans
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Hyaluronic Acid
(therapeutic use)
- Male
- Remission Induction
- Retrospective Studies
- Time Factors
- Ureteroscopy
- Urethra
(diagnostic imaging)
- Urination
- Vesico-Ureteral Reflux
(diagnostic imaging, therapy)
|